Australia markets close in 1 hour 15 minutes

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
33.78+0.74 (+2.24%)
At close: 04:00PM EST
34.05 +0.27 (+0.80%)
After hours: 07:53PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 1.01B
Enterprise value 455.61M
Trailing P/E 3.82
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.29
Price/book (mrq)0.79
Enterprise value/revenue 0.57
Enterprise value/EBITDA 1.15

Trading information

Stock price history

Beta (5Y monthly) 1.58
52-week change 3-49.15%
S&P500 52-week change 3-12.46%
52-week high 373.47
52-week low 328.53
50-day moving average 333.15
200-day moving average 345.00

Share statistics

Avg vol (3-month) 3273.15k
Avg vol (10-day) 3169.57k
Shares outstanding 530.23M
Implied shares outstanding 6N/A
Float 819.71M
% held by insiders 133.80%
% held by institutions 146.40%
Shares short (12 Jan 2023) 41.17M
Short ratio (12 Jan 2023) 43.96
Short % of float (12 Jan 2023) 46.55%
Short % of shares outstanding (12 Jan 2023) 43.88%
Shares short (prior month 14 Dec 2022) 41.19M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022

Profitability

Profit margin 33.82%
Operating margin (ttm)46.70%

Management effectiveness

Return on assets (ttm)17.95%
Return on equity (ttm)23.19%

Income statement

Revenue (ttm)802.93M
Revenue per share (ttm)26.60
Quarterly revenue growth (yoy)-53.60%
Gross profit (ttm)777.05M
EBITDA 401.14M
Net income avi to common (ttm)271.57M
Diluted EPS (ttm)8.65
Quarterly earnings growth (yoy)-98.60%

Balance sheet

Total cash (mrq)571.06M
Total cash per share (mrq)19.4
Total debt (mrq)39.92M
Total debt/equity (mrq)3.12
Current ratio (mrq)6.80
Book value per share (mrq)43.03

Cash flow statement

Operating cash flow (ttm)297.4M
Levered free cash flow (ttm)240.13M